XML 35 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2018
Fair Value Disclosures [Abstract]  
Assets and Liabilities Measured at Fair Value on Recurring Basis
Except for the Company’s Level 2 liabilities which are discussed in Note 9, “Convertible Senior Notes,” the following table sets forth the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2018 and December 31, 2017, by level, within the fair value hierarchy:

 
As of September 30, 2018
 
As of December 31, 2017
Assets and Liabilities
Quoted Prices In
Active Markets for Identical Assets
(Level 1)
 
Significant Other Observable Inputs
 (Level 2)
 
Significant
Unobservable
Inputs
 (Level 3)
 
Balance as of September 30, 2018
 
Quoted Prices In
Active Markets for Identical Assets
(Level 1)
 
Significant Other Observable Inputs
 (Level 2)
 
Significant
Unobservable
Inputs
 (Level 3)
 
Balance as of December 31, 2017
 
(in thousands)
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash equivalents
$
12,237

 
$

 
$

 
$
12,237

 
$
12,100

 
$

 
$

 
$
12,100

Short-term investment
13,089

 

 

 
13,089

 

 

 

 

Total assets at fair value
$
25,326

 
$

 
$

 
$
25,326

 
$
12,100

 
$

 
$

 
$
12,100

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contingent purchase price
$

 
$

 
$
18,822

 
$
18,822

 
$

 
$

 
$
19,650

 
$
19,650

Total liabilities at fair value
$

 
$

 
$
18,822

 
$
18,822

 
$

 
$

 
$
19,650

 
$
19,650



Fair Value Inputs, Quantitative Information
The following table provides quantitative information associated with the fair value measurements of the Company’s Level 3 liabilities:
 
 
Fair Value as of
September 30, 2018
 
Valuation Technique
 
Unobservable Input
 
Range
(Weighted Average)
 
 
(in thousands)
 
 
 
 
 
 
Rempex:
 
 
 
 
 
 
 
 
Contingent purchase price: Event-based milestones
 
$
18,822

 
Probability-adjusted discounted cash flow
 
Probabilities of successes
 
18% - 75% (46%)
 
 
 
 
 
 
Period in which milestones are expected to be achieved
 
2018 - 2024
 
 
 
 
 
 
Discount rate
 
5.0% - 7.3%
 
 
Fair Value as of
December 31, 2017
 
Valuation Technique
 
Unobservable Input
 
Range
(Weighted Average)
 
 
(in thousands)
 
 
 
 
 
 
Rempex:
 
 
 
 
 
 
 
 
Contingent purchase price: Event-based milestones
 
$
19,650

 
Probability-adjusted discounted cash flow
 
Probabilities of successes
 
18% - 90% (71%)
 
 
 
 
 
 
Period in which milestones are expected to be achieved
 
2018 - 2024
 
 
 
 
 
 
Discount rate
 
4.8% - 7.5%
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The changes in fair value of the Company’s Level 3 contingent purchase price during the three and nine months ended September 30, 2018 and 2017 were as follows:

 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2018
 
2017
 
2018
 
2017
 
(in thousands)
 
(in thousands)
 
 
Balance at beginning of period
$
18,825

 
$
20,300

 
$
19,650

 
$
31,832

Payments
(3
)
 

 
(570
)
 

Fair value adjustments to contingent purchase prices included in net loss

 
(1,600
)
 
(258
)
 
(13,132
)
Balance at end of period
$
18,822

 
$
18,700

 
$
18,822

 
$
18,700